Pricing Log in Create free account

AN2 Therapeutics, Inc. (ANTX) vs Molecular Partners AG Sponsored ADR (MOLN)

AN2 Therapeutics, Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. AN2 Therapeutics, Inc. and Molecular Partners AG Sponsored ADR are of similar size ($143.5M and $135.9M). Across the 8 metrics below, AN2 Therapeutics, Inc. leads on 7 and Molecular Partners AG Sponsored ADR on 1.

Valuation

Metric ANTX MOLN Biotechnology median
P/E n/m n/m 8.42
P/S n/m 25.33 10.01
P/B 2.12 1.93 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m 10.10 9.41
Earnings yield (29.81%) (46.34%) (31.85%)
Free cash flow yield (19.09%) (40.13%) (24.58%)

Profitability

Metric ANTX MOLN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.12%) (63.89%) (56.36%)
Return on assets (46.06%) (52.73%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANTX MOLN Biotechnology median
Revenue growth (TTM) — (27.99%) 6.02%
EPS growth (last fiscal year) 32.56% (9.94%) 30.26%
Revenue growth, 5-year CAGR — (23.12%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANTX MOLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.32 7.27 4.72
Net debt to EBITDA 1.48 1.66 0.96

Dividend

Metric ANTX MOLN Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ANTX MOLN Biotechnology median
Market cap 135.85m 143.47m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack